Emyria Ltd News

Emyria Ltd: Appendix 4G and Corporate Governance Statement

Oct 11 00:50 ET

Emyria Ltd: Change of Director's Interest Notice x 2

Sep 22 22:38 ET

Emyria Ltd: 2024 Annual General Meeting - Key Dates

Sep 16 03:27 ET

Emyria Ltd: Emyria Shares Interim Success in PTSD Treatment Program

Sep 1 19:50 ET

Emyria Ltd: June 2024 Quarterly Activities Report and Appendix 4C

Jul 29 19:06 ET

Emyria Ltd: Emyria, UWA Secure $499K Grant for MDMA Analogue Program

Jun 30 19:30 ET

Emyria Ltd: Empax Centre Selected As Key Site In Global PTSD Study

Jun 19 18:21 ET

Emyria Ltd: Management Changes

Jun 10 18:22 ET

Emyria Ltd: March 2024 Quarterly Activities Report and Appendix 4C

Apr 25 18:40 ET

Emyria Ltd: Trading Halt

Apr 18 19:14 ET

Emyria Ltd: Emyria Opens Empax Centre to Advance Mental Health Care

Apr 9 18:23 ET

Emyria Ltd: Emyria Expands Specialist AP Team - First Female for MDMA-AT

Apr 4 17:25 ET

Emyria Ltd: Emyria, Reach Wellness Enter MDMA-AT Research Agreement

Apr 2 17:25 ET

Emyria Ltd: Response to ASX Aware Query

Mar 12 02:58 ET

Emyria Ltd: Response to ASX Price Query

Mar 7 17:56 ET

Emyria Ltd: December 2023 Quarterly Activities Report and Appendix 4C

Jan 30 17:32 ET

Emyria Ltd: Emyria Receives $2.5M R&D Tax Incentive Refund

Jan 14 17:29 ET

Emyria Ltd: Emyria Specialist Granted Authorised Prescriber Status

Jan 9 17:28 ET

Emyria Ltd: Change of Director's Interest Notice - M. Winlo

Jan 2 03:43 ET

Emyria Ltd: Initial Director's Interest Notice - G. Hutchinson

Nov 21, 2023 16:59 ET